Cargando…
Rapid Development of the FDA ACMT COVID-19 ToxIC (FACT) Pharmacovigilance Pilot Project to Monitor Adverse Events Reported in Association with COVID-19 Therapeutics
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier B.V. Published by Elsevier B.V.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461783/ http://dx.doi.org/10.1016/S0378-4274(21)00280-0 |